Cited 12 times in
Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김원호 | - |
dc.contributor.author | 천재희 | - |
dc.date.accessioned | 2017-10-26T07:30:34Z | - |
dc.date.available | 2017-10-26T07:30:34Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1976-2283 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/152122 | - |
dc.description.abstract | BACKGROUND/AIMS: C-reactive protein (CRP) is an easily measured index of disease activity, but its ability to predict clinical course is controversial. We therefore designed a study to determine whether the CRP level at Crohn's disease (CD) diagnosis is a valuable indicator of the disease phenotype, activity, and clinical course. METHODS: We retrospectively analyzed 705 CD patients from 32 institutions. The patients were classified into two groups according to CRP level. The patients' demographic and clinical characteristics and their use of immunosuppressive or biological agents were recorded. Disease location and behavior, hospitalization, and surgery were analyzed. RESULTS: A high CRP was associated with younger age, steroid use, colonic or ileocolonic location, high CD activity index, and active inflammation at colonoscopy (p<0.001). As the disease progressed, patients with high CRP were more likely to exhibit strictures (p=0.027). There were significant differences in the use of 5-aminosalicylic acid, antibiotics, corticosteroids, azathioprine, and infliximab (p<0.001, p<0.001, p<0.001, p<0.001, and p=0.023, respectively). Hospitalization was also more frequent in patients with high CRP. CONCLUSIONS: The CRP level at diagnosis is useful for evaluating the phenotype, activity, and clinical course of CD. Closer follow-up strategies, with early aggressive treatment, could be considered for patients with high CRP. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Editorial Office of Gut and Liver | - |
dc.relation.isPartOf | GUT AND LIVER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adolescent | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Anti-Inflammatory Agents, Non-Steroidal/therapeutic use | - |
dc.subject.MESH | Biomarkers/blood | - |
dc.subject.MESH | C-Reactive Protein/analysis* | - |
dc.subject.MESH | Colon/pathology | - |
dc.subject.MESH | Colonoscopy | - |
dc.subject.MESH | Constriction, Pathologic | - |
dc.subject.MESH | Crohn Disease/blood* | - |
dc.subject.MESH | Crohn Disease/drug therapy | - |
dc.subject.MESH | Crohn Disease/pathology | - |
dc.subject.MESH | Disease Progression | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Hospitalization/statistics & numerical data | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Ileum/pathology | - |
dc.subject.MESH | Immunosuppressive Agents/therapeutic use | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Phenotype | - |
dc.subject.MESH | Predictive Value of Tests | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Severity of Illness Index* | - |
dc.subject.MESH | Young Adult | - |
dc.title | Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study | - |
dc.type | Article | - |
dc.publisher.location | Korea (South) | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Internal Medicine | - |
dc.contributor.googleauthor | Jee Hye Kwon | - |
dc.contributor.googleauthor | Jong Pil Im | - |
dc.contributor.googleauthor | Byong Duk Ye | - |
dc.contributor.googleauthor | Jae Hee Cheon | - |
dc.contributor.googleauthor | Hyun Joo Jang | - |
dc.contributor.googleauthor | Kang Moon Lee | - |
dc.contributor.googleauthor | You Sun Kim | - |
dc.contributor.googleauthor | Sang Wook Kim | - |
dc.contributor.googleauthor | Young Ho Kim | - |
dc.contributor.googleauthor | Geun Am Song | - |
dc.contributor.googleauthor | Dong Soo Han | - |
dc.contributor.googleauthor | Won Ho Kim | - |
dc.contributor.googleauthor | Joo Sung Kim | - |
dc.identifier.doi | 10.5009/gnl15411 | - |
dc.contributor.localId | A04030 | - |
dc.contributor.localId | A00774 | - |
dc.relation.journalcode | J00954 | - |
dc.identifier.eissn | 2005-1212 | - |
dc.identifier.pmid | 27021506 | - |
dc.subject.keyword | C-reactive protein | - |
dc.subject.keyword | Clinical course | - |
dc.subject.keyword | Crohn disease | - |
dc.contributor.alternativeName | Kim, Won Ho | - |
dc.contributor.alternativeName | Cheon, Jae Hee | - |
dc.contributor.affiliatedAuthor | Cheon, Jae Hee | - |
dc.contributor.affiliatedAuthor | Kim, Won Ho | - |
dc.citation.volume | 10 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 595 | - |
dc.citation.endPage | 603 | - |
dc.identifier.bibliographicCitation | GUT AND LIVER, Vol.10(4) : 595-603, 2016 | - |
dc.date.modified | 2017-10-24 | - |
dc.identifier.rimsid | 46902 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.